STATCenter·
STAT+: Roivant lung disease drug hits mid-stage study goals
These positive results could open up a new way to treat serious lung disease.
Read at STAT →
Health · 1 sources covering this
STAT+: Roivant lung disease drug hits mid-stage study goals
These positive results could open up a new way to treat serious lung disease.
Coverage spectrum
0 L · 1 C · 0 R
How 1 sources are covering this
Embed this bias spectrum on your site
Paste this iframe wherever you'd like the widget to appear. Resizes responsively; no JS required.
<iframe src="https://statesidedaily.com/embed/cluster/8a84d37b76f9429349629adaee13d7c4599bd221" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="STAT+: Roivant lung disease drug hits mid-stage study goals"></iframe>
